ABIN1302526

antibody from antibodies-online

Targeting: CD33 FLJ00391, p67, SIGLEC-3, SIGLEC3

Western blot (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Immunoprecipitation (Recommended by provider)

Immunohistochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

ABIN1302526

Provider

antibodies-online

Product name

anti-CD33 Molecule (CD33) antibody

Antibody type

Monoclonal

Description

Purified by protein A

Reactivity

Human

Host

Mouse

Isotype

IgG

Antibody clone number

WM53

Vial size

0.1 mg

Storage

Store at 2-8°C. Do not freeze. Do not use after expiration date stamped on vial label.

Handling

Do not freeze.

References

Submitted references

Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function.

Leone AM, Rutella S, Bonanno G, Abbate A, Rebuzzi AG, Giovannini S, Lombardi M, Galiuto L, Liuzzo G, Andreotti F, Lanza GA, Contemi AM, Leone G, Crea F
European heart journal 2005 Jun;26(12):1196-204

---

Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine.

Schenk M, Bouchon A, Birrer S, Colonna M, Mueller C
Journal of immunology (Baltimore, Md. : 1950) 2005 Jan 1;174(1):517-24

---

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells.

Garnache-Ottou F, Chaperot L, Biichle S, Ferrand C, Remy-Martin JP, Deconinck E, de Tailly PD, Bulabois B, Poulet J, Kuhlein E, Jacob MC, Salaun V, Arock M, Drenou B, Schillinger F, Seilles E, Tiberghien P, Bensa JC, Plumas J, Saas P
Blood 2005 Feb 1;105(3):1256-64

---

Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: engagement of CD33 induces apoptosis of leukemic cells.

Vitale C, Romagnani C, Puccetti A, Olive D, Costello R, Chiossone L, Pitto A, Bacigalupo A, Moretta L, Mingari MC
Proceedings of the National Academy of Sciences of the United States of America 2001 May 8;98(10):5764-9

---

Expression of leukemia-associated antigen, JL1, in bone marrow and thymus.

Shin YK, Choi EY, Kim SH, Chung J, Chung DH, Park WS, Jung KC, Kim HS, Park S, Kim HJ, Park MH, Min CK, Kim CC, Park SH
The American journal of pathology 2001 Apr;158(4):1473-80

---

Unusual immunophenotypes in acute leukaemias: incidence and clinical correlations.

Bradstock KF, Kirk J, Grimsley PG, Kabral A, Hughes WG
British journal of haematology 1989 Aug;72(4):512-8

---

Further characterization of human myeloid antigens (gp160,95; gp150; gp67): investigation of epitopic heterogeneity and non-haemopoietic distribution using panels of monoclonal antibodies belonging to CD-11b, CD-13 and CD-33.

Favaloro EJ, Bradstock KF, Kabral A, Grimsley P, Zowtyj H, Zola H
British journal of haematology 1988 Jun;69(2):163-71

---

Characterization of monoclonal antibodies to the human myeloid-differentiation antigen, 'gp67' (CD-33).

Favaloro EJ, Bradstock KF, Kabral A, Grimsley P, Berndt MC
Disease markers 1987 Dec;5(4):215-25